DE3750197D1 - Antagonisten des Fibroblasten-Wachstumsfaktors. - Google Patents
Antagonisten des Fibroblasten-Wachstumsfaktors.Info
- Publication number
- DE3750197D1 DE3750197D1 DE3750197T DE3750197T DE3750197D1 DE 3750197 D1 DE3750197 D1 DE 3750197D1 DE 3750197 T DE3750197 T DE 3750197T DE 3750197 T DE3750197 T DE 3750197T DE 3750197 D1 DE3750197 D1 DE 3750197D1
- Authority
- DE
- Germany
- Prior art keywords
- antagonists
- arg
- growth factor
- fibroblast growth
- fgf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000005557 antagonist Substances 0.000 title abstract 3
- 102000018233 Fibroblast Growth Factor Human genes 0.000 title abstract 2
- 108050007372 Fibroblast Growth Factor Proteins 0.000 title abstract 2
- 229940126864 fibroblast growth factor Drugs 0.000 title abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 108091008794 FGF receptors Proteins 0.000 abstract 1
- 102000044168 Fibroblast Growth Factor Receptor Human genes 0.000 abstract 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 230000010261 cell growth Effects 0.000 abstract 1
- 210000002889 endothelial cell Anatomy 0.000 abstract 1
- 229960002897 heparin Drugs 0.000 abstract 1
- 229920000669 heparin Polymers 0.000 abstract 1
- 230000001817 pituitary effect Effects 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85484386A | 1986-04-22 | 1986-04-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3750197D1 true DE3750197D1 (de) | 1994-08-18 |
Family
ID=25319659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3750197T Expired - Lifetime DE3750197D1 (de) | 1986-04-22 | 1987-04-21 | Antagonisten des Fibroblasten-Wachstumsfaktors. |
Country Status (6)
Country | Link |
---|---|
US (1) | US5132408A (de) |
EP (1) | EP0246753B1 (de) |
JP (1) | JPS62259598A (de) |
AT (1) | ATE108459T1 (de) |
AU (1) | AU7180787A (de) |
DE (1) | DE3750197D1 (de) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5252718A (en) * | 1986-04-22 | 1993-10-12 | The Salk Institute For Biological Studies | Fibroblast growth factor antagonists |
US5852177A (en) * | 1987-02-24 | 1998-12-22 | Takeda Chemical Industries, Ltd. | Basic fibroblast growth factor (bFGF) muteins |
AU650292B2 (en) * | 1990-09-14 | 1994-06-16 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | A non-mitogenic competitive HGF antagonist |
US5821223A (en) | 1990-09-14 | 1998-10-13 | The United States Of America As Represented By The Department Of Health And Human Services | Method of stimulating cell growth with a novel broad spectrum human lung fibroblast-derived mitogen |
US6566098B1 (en) | 1990-09-14 | 2003-05-20 | The United States Of America As Represented By The Department Of Health And Human Services | DNA encoding truncated hepatocyte growth factor variants |
US5206354A (en) * | 1990-11-23 | 1993-04-27 | American Cyanamid Company | Dna sequence encoding active fragment of fibroblast growth factor, hbf-2 |
AU1052492A (en) * | 1991-01-31 | 1992-08-06 | Farmitalia Carlo Erba S.R.L. | Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent |
WO1992013958A1 (en) * | 1991-02-06 | 1992-08-20 | Georgetown University | Receptor blocking peptides of fibroblast growth factor receptor |
US5688768A (en) * | 1991-02-19 | 1997-11-18 | Cor Therapeutics, Inc. | Recombinant thrombin receptor and related pharmaceuticals |
US7119182B1 (en) | 1991-02-19 | 2006-10-10 | The Regents Of The University Of California | Recombinant thrombin receptor and related pharmaceuticals |
EP0505108B1 (de) * | 1991-03-21 | 1995-10-18 | The Procter & Gamble Company | Mittel zur Kontrolle von Hautfalten, die die Arg-Ser-Arg-Lys-Sequenzen enthalten |
US5492894A (en) * | 1991-03-21 | 1996-02-20 | The Procter & Gamble Company | Compositions for treating wrinkles comprising a peptide |
US5326695A (en) * | 1992-05-15 | 1994-07-05 | Ludwig Institute For Cancer Research | Platelet derived growth factor agonists |
US5444151A (en) * | 1992-05-15 | 1995-08-22 | Ludwig Institute For Cancer Research | Platelet derived growth factor antagonists |
JPH08500246A (ja) * | 1992-08-10 | 1996-01-16 | ケンブリッジ ニューロサイエンス インコーポレーテッド | 細胞増殖の阻害剤,その調製および用途 |
IL108367A0 (en) * | 1993-01-27 | 1994-04-12 | Hektoen Inst For Medical Resea | Antisense polynzcleotide inhibition of human growth factor-sensitive cancer cells |
US5571787A (en) | 1993-07-30 | 1996-11-05 | Myelos Corporation | Prosaposin as a neurotrophic factor |
WO1996039509A1 (en) * | 1995-06-05 | 1996-12-12 | Human Genome Sciences, Inc. | Fibroblast growth factor 15 |
US5773252A (en) * | 1995-06-05 | 1998-06-30 | Human Genome Sciences, Inc. | Fibroblast growth factor 15 |
US6271196B1 (en) | 1996-03-05 | 2001-08-07 | Regents Of The University Of Ca | Methods of alleviating neuropathic pain using prosaposin-derived peptides |
US6849602B1 (en) | 1996-03-05 | 2005-02-01 | The Regents Of The University Of California | Compositions for alleviating neuropathic pain with prosaposin receptor agonists |
AU722626B2 (en) * | 1996-05-20 | 2000-08-10 | Abburi Ramaiah | Cosmetic preparation |
US6143723A (en) * | 1996-05-20 | 2000-11-07 | Ramaiah; Abburi | Pigmentory agent |
US6214795B1 (en) | 1996-11-12 | 2001-04-10 | Praecis Pharmaceuticals, Inc. | Peptide compounds useful for modulating FGF receptor activity |
EP0979238A4 (de) * | 1997-03-05 | 2000-08-23 | Univ California | Methode zur heilung neuropathischer schmerzen |
US6274712B1 (en) | 1997-12-23 | 2001-08-14 | 3-Dimensional Pharmaceuticals, Inc. | Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137 |
US6548634B1 (en) | 1998-09-30 | 2003-04-15 | Chiron Corporation | Synthetic peptides having FGF receptor affinity |
ITRM20010088A1 (it) * | 2001-02-21 | 2002-08-21 | Idi Irccs | Peptide in grado di inibire l'attivita' del fattore di crescita derivato dalle piastrine (pdgf-bb) e del fattore di crescita derivato dai fi |
EP2489363A3 (de) * | 2005-09-13 | 2012-12-05 | Abburi Ramaiah | Agonist Peptide des basischen Fibroblasten-Wachstumsfaktor (bFGF) und Verfahren zur Verminderung von Falten auf der Haut, Haare und Verdunkelung der Beschleunigung der Wundheilung |
JP5360738B2 (ja) * | 2008-03-03 | 2013-12-04 | 国立大学法人 奈良先端科学技術大学院大学 | 細胞増殖促進活性を有するペプチド |
JP2012518657A (ja) | 2009-02-25 | 2012-08-16 | オーエスアイ・ファーマシューティカルズ,エルエルシー | 併用抗癌治療 |
JP2012519281A (ja) | 2009-02-27 | 2012-08-23 | オーエスアイ・ファーマシューティカルズ,エルエルシー | 間葉様腫瘍細胞またはその生成を阻害する薬剤を同定するための方法 |
WO2010099138A2 (en) | 2009-02-27 | 2010-09-02 | Osi Pharmaceuticals, Inc. | Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
JP2012519282A (ja) | 2009-02-27 | 2012-08-23 | オーエスアイ・ファーマシューティカルズ,エルエルシー | 間葉様腫瘍細胞またはその生成を阻害する薬剤を同定するための方法 |
JP5767314B2 (ja) | 2010-04-16 | 2015-08-19 | ソーク インスティチュート フォー バイオロジカル スタディーズ | Fgfを用いて代謝障害を処置するための方法 |
CN102212568A (zh) * | 2011-03-22 | 2011-10-12 | 深圳大学 | 用酶催化合成药物l-多巴的方法 |
EP2702173A1 (de) | 2011-04-25 | 2014-03-05 | OSI Pharmaceuticals, LLC | Verwendung von emt-gensignaturen bei der entdeckung von krebswirkstoffen, -diagnostika und -behandlungen |
AU2012251699A1 (en) * | 2011-05-02 | 2013-05-09 | Baxter Healthcare S.A. | FGF based fibrin binding peptides |
US9475856B2 (en) | 2012-03-02 | 2016-10-25 | New York University | Chimeric FGF21 proteins with enhanced binding affinity for β-klotho for the treatment of type II diabetes, obesity, and related metabolic disorders |
WO2013152252A1 (en) | 2012-04-06 | 2013-10-10 | OSI Pharmaceuticals, LLC | Combination anti-cancer therapy |
US9657075B2 (en) | 2012-06-07 | 2017-05-23 | New York University | Chimeric fibroblast growth factor 23 proteins and methods of use |
US9474785B2 (en) | 2012-06-07 | 2016-10-25 | New York University | Chimeric fibroblast growth factor 19 proteins and methods of use |
US9464126B2 (en) | 2012-06-07 | 2016-10-11 | New York University | Chimeric fibroblast growth factor 21 proteins and methods of use |
WO2014130659A1 (en) | 2013-02-22 | 2014-08-28 | New York University | Chimeric fibroblast growth factor 23 proteins and methods of use |
JP6621752B2 (ja) | 2013-10-21 | 2019-12-18 | ソーク インスティテュート フォー バイオロジカル スタディーズ | 変異した線維芽細胞増殖因子(fgf)1および使用方法 |
WO2015061331A1 (en) | 2013-10-21 | 2015-04-30 | Salk Institute For Biological Studies | Chimeric fibroblast growth factor (fgf) 2/fgf1 peptides and methods of use |
WO2017075260A1 (en) | 2015-10-30 | 2017-05-04 | Salk Institute For Biological Studies | Treatment of steroid-induced hyperglycemia with fibroblast growth factor (fgf) 1 analogs |
US11542309B2 (en) | 2019-07-31 | 2023-01-03 | Salk Institute For Biological Studies | Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose |
CN112110988A (zh) * | 2020-08-21 | 2020-12-22 | 温州医科大学 | 一种具有毛发生长作用的多肽类似物及制备方法和应用 |
CN117886917B (zh) * | 2024-01-17 | 2024-07-23 | 南通大学附属医院 | 一种VEGF和bFGF的模拟肽片段组合及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4444760A (en) * | 1983-06-17 | 1984-04-24 | Merck & Co., Inc. | Purification and characterization of a protein fibroblast growth factor |
EP0248819B2 (de) * | 1985-09-12 | 2000-08-30 | Scios Inc. | Rekombinanter fibroblast-wachstumsfaktor |
-
1987
- 1987-04-21 DE DE3750197T patent/DE3750197D1/de not_active Expired - Lifetime
- 1987-04-21 EP EP87303489A patent/EP0246753B1/de not_active Expired - Lifetime
- 1987-04-21 AT AT87303489T patent/ATE108459T1/de not_active IP Right Cessation
- 1987-04-21 AU AU71807/87A patent/AU7180787A/en not_active Abandoned
- 1987-04-22 JP JP62099638A patent/JPS62259598A/ja active Pending
-
1988
- 1988-11-14 US US07/270,225 patent/US5132408A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU622708B2 (en) | 1992-04-16 |
AU7180787A (en) | 1987-10-29 |
US5132408A (en) | 1992-07-21 |
EP0246753A3 (en) | 1989-06-07 |
EP0246753A2 (de) | 1987-11-25 |
AU4235089A (en) | 1990-01-18 |
ATE108459T1 (de) | 1994-07-15 |
JPS62259598A (ja) | 1987-11-11 |
EP0246753B1 (de) | 1994-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3750197D1 (de) | Antagonisten des Fibroblasten-Wachstumsfaktors. | |
ATE81779T1 (de) | Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren. | |
ES2147558T3 (es) | Nuevos polipeptidos para promover la fijacion celular. | |
PH20343A (en) | Cysteline-depleted muteins of biologically active proteins | |
ATE39700T1 (de) | Synthetisches hitzestabiles enterotoxinpolypeptid und dessen multimere. | |
DE69534569D1 (de) | Hiv-1- und hiv-2-peptide zur hemmung von mit membranfusionen in zusammenhang stehenden phänomenen, einschliesslich der übertragung von hiv | |
DE69630708D1 (de) | An den erythropoietin-rezeptor bindende zusammensetzungen und peptide | |
YU49126B (sh) | Varijantni cd44-površinski proteini, dna-sekvence koje ih kodiraju i antitela protiv ovih proteina | |
ATE372382T1 (de) | Ein faktor viii-polypeptid mit faktor viii:c- aktivität | |
DE69132275D1 (de) | Beta-type ähnlicher transformierender wachstumfaktor | |
DE69126487D1 (de) | cDNA für Ratten C-Typ natriuretisches Peptid und Vorläuferprotein | |
ATE81345T1 (de) | Synthetische atriale peptide. | |
KR900702027A (ko) | 사람 / 소의 염기성 섬유 아세포 성장 인자의 유도체 | |
ES2095255T3 (es) | Analogos de sustitucion de peptidos magainina. | |
ATE141947T1 (de) | Klonierung eines neuen mitgliedes der familie der fibroblasten-wachstumsfaktoren (fgf)-rezeptoren | |
DK1612555T3 (da) | Kryptiske peptider til anvendelse til at inducere immunologisk tolerance | |
DK0938555T3 (da) | Konstruktioner og komplekser af cyclin E | |
ATE432985T1 (de) | Polypeptide mit aktivität der stimulierung von neutrophilen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |